Skip to main content
Fig. 2 | BMC Medical Informatics and Decision Making

Fig. 2

From: Analytical validation of Exandra: a clinical decision support system for promoting guideline-directed therapy of type-2 diabetes in primary care – a collaborative study with experts from Diabetes Canada

Fig. 2

A and B Screenshots of user interface presenting examples of Exandra recommendation outputs. ASCVD, atherosclerotic cardiovascular disease; BP, blood pressure; CKD, chronic kidney disease; CV, cardiovascular; DPP-4, dipeptidyl peptidase 4; eGFR, estimated glomerular filtration rate; GLP-1, glucagon-like peptide-1; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; HF, heart failure; HHF, hypertensive heart failure; LDL-C, low-density lipoprotein cholesterol; MACE, major adverse cardiovascular event; M, male; non-HDL-C, non-high-density lipoprotein cholesterol; SGLT2, sodium-glucose transport protein 2

Back to article page